 
    Aflac Incorporated, known for its supplemental health and life insurance products, operates successfully across two major regions: the U.S and Japan. This diversified geographical presence provides a competitive edge. The company's strong fundamentals, balanced with moderate debt, indicate a promising position in the market.
Aflac shows a solid overall performance with strengths in equity returns and asset management, though some challenges may exist in the debt-equity sphere.
| Category | Score | Visualization | 
|---|---|---|
| Overall | 4 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 3 | |
| Price to Book | 1 | 
The historical data reflects consistent scores, with recent improvements in key areas suggesting positive future prospects.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B | 
|---|---|---|---|---|---|---|---|
| 2025-04-24 | 4 | 4 | 5 | 5 | 2 | 3 | 1 | 
| Historical | 0 | 4 | 5 | 5 | 2 | 3 | 1 | 
Analyst price targets point towards a consistent consensus, indicating stability and limited volatility in expected stock performance.
| High | Low | Median | Consensus | 
|---|---|---|---|
| 102 | 102 | 102 | 102 | 
 
The sentiment among analysts is predominantly neutral, with a majority holding a steady position on the stock.
| Recommendation | Count | Visualization | 
|---|---|---|
| Strong Buy | 0 | |
| Buy | 9 | |
| Hold | 14 | |
| Sell | 2 | |
| Strong Sell | 0 | 
Aflac Incorporated presents a robust investment opportunity with stable returns on equity and assets, while moderate risks arise from its debt levels. The company's forward momentum appears healthy, reinforced by a consistent analyst price consensus. However, potential investors should remain cautious of any market changes that could impact the insurance industry. Overall, Aflac's diversified portfolio and geographical spread provide a solid foundation for future growth.